Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors As Adjuvant Therapy in Completely Resected Non-Small-Cell Lung Cancer

被引：14
作者：
Novello, Silvia [1 ]
机构：
[1] Univ Turin, Turin, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 34期
关键词：
VINORELBINE PLUS CISPLATIN; PHASE-III TRIAL; CHEMOTHERAPY; GEFITINIB; PLACEBO; ASSOCIATION; GUIDELINE; SELECTION; EGFR;
D O I：
10.1200/JCO.2015.63.7587
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3985 / +
页数：3
相关论文
共 21 条
[1]   Influence of Chemotherapy on EGFR Mutation Status Among Patients With Non-Small-Cell Lung Cancer [J].
Bai, Hua ;
Wang, Zhijie ;
Chen, Keneng ;
Zhao, Jun ;
Lee, J. Jack ;
Wang, Shuhang ;
Zhou, Qinghua ;
Zhuo, Minglei ;
Mao, Li ;
An, Tongtong ;
Duan, Jianchun ;
Yang, Lu ;
Wu, Meina ;
Liang, Zhen ;
Wang, Yuyan ;
Kang, Xiaozheng ;
Wang, Jie .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (25) :3077-3083
[2]   Randomized International Phase III Trial of ERCC1 and RRM1 Expression-Based Chemotherapy Versus Gemcitabine/Carboplatin in Advanced Non-Small-Cell Lung Cancer [J].
Bepler, Gerold ;
Williams, Charles ;
Schell, Michael J. ;
Chen, Wei ;
Zheng, Zhong ;
Simon, George ;
Gadgeel, Shirish ;
Zhao, Xiuhua ;
Schreiber, Fred ;
Brahmer, Julie ;
Chiappori, Alberto ;
Tanvetyanon, Tawee ;
Pinder-Schenck, Mary ;
Gray, Jhanelle ;
Haura, Eric ;
Antonia, Scott ;
Fischer, Juergen R. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (19) :2404-+
[3]   Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]):: a randomised controlled trial [J].
Douillard, Jean-Yves ;
Rosell, Rafael ;
De Lena, Mario ;
Carpagnano, Francesco ;
Ramlau, Rodryg ;
Gonzales-Larriba, Jose Luis ;
Grodzki, Tornasz ;
Pereira, Jose Rodrigues ;
Le Groumellec, Alain ;
Lorusso, Vito ;
Clary, Claude ;
Torres, Antonio J. ;
Dahabreh, Jabrail ;
Souquet, Pierre-Jean ;
Astudillo, Julio ;
Fournel, Pierre ;
Artal-Cortes, Angel ;
Jassem, Jacek ;
Koubkova, Leona ;
His, Patricia ;
Riggi, Marcella ;
Hurteloup, Patrick .
LANCET ONCOLOGY, 2006, 7 (09) :719-727
[4]   Gefitinib Versus Placebo in Completely Resected Non-Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study [J].
Goss, Glenwood D. ;
O'Callaghan, Chris ;
Lorimer, Ian ;
Tsao, Ming-Sound ;
Masters, Gregory A. ;
Jett, James ;
Edelman, Martin J. ;
Lilenbaum, Rogerio ;
Choy, Hak ;
Khuri, Fadlo ;
Pisters, Katherine ;
Gandara, David ;
Kernstine, Kemp ;
Butts, Charles ;
Noble, Jonathan ;
Hensing, Thomas A. ;
Rowland, Kendrith ;
Schiller, Joan ;
Ding, Keyue ;
Shepherd, Frances A. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (27) :3320-+
[5]   Adjuvant Chemotherapy for the Completely Resected Stage IB Nonsmall Cell Lung Cancer [J].
He, Jiaxi ;
Shen, Jianfei ;
Yang, Chenglin ;
Jiang, Long ;
Liang, Wenhua ;
Shi, Xiaoshun ;
Xu, Xin ;
He, Jianxing .
MEDICINE, 2015, 94 (22) :e903
[6]   Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023 [J].
Kelly, Karen ;
Chansky, Kari ;
Gaspar, Laurie E. ;
Albain, Kathy S. ;
Jett, James ;
Ung, Yee C. ;
Lau, Derick H. M. ;
Crowley, John J. ;
Gandara, David R. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15) :2450-2456
[7]   Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial [J].
Kelly, Karen ;
Altorki, Nasser K. ;
Eberhardt, Wilfried E. E. ;
O'Brien, Mary E. R. ;
Spigel, David R. ;
Crino, Lucio ;
Tsai, Chun-Ming ;
Kim, Joo-Hang ;
Cho, Eun Kyung ;
Hoffman, Philip C. ;
Orlov, Sergey V. ;
Serwatowski, Piotr ;
Wang, Jiuzhou ;
Foley, Margaret A. ;
Horan, Julie D. ;
Shepherd, Frances A. .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (34) :4007-+
[8]   Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer [J].
Le Chevalier, T ;
Arriagada, R ;
Le Péchoux, C ;
Grunenwald, D ;
Dunant, A ;
Pignon, JP ;
Tarayre, M ;
Abratt, R ;
Arriagada, R ;
Bergman, B ;
Gralla, R ;
Grunenwald, D ;
Le Chevalier, T ;
Orlowski, T ;
Papadakis, E ;
Pinel, MIS ;
Araujo, C ;
Della Torre, H ;
de Solchaga, MM ;
Abdi, E ;
Blum, R ;
Ball, D ;
Basser, R ;
De Boer, R ;
Bishop, J ;
Brigham, B ;
Davis, S ;
Fox, D ;
Richardson, G ;
Wyld, D ;
Pirker, R ;
Humblet, Y ;
Delaunois, L ;
Van Meerbeeck, JP ;
Germonpre, P ;
Vansteenkiste, J ;
Nackaerts, K ;
Pinel, MIS ;
Vauthier, G ;
Younes, RN ;
Arriagada, R ;
Baeza, R ;
Carvajal, P ;
Kleinman, S ;
Orlandi, L ;
Castro, C ;
Godoy, J ;
Kosatova, K ;
Gaafar, R ;
Azarian, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (04) :351-360
[9]   Molecular Testing for Selection of Patients With Lung Cancer for Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Guideline [J].
Leighl, Natasha B. ;
Rekhtman, Natasha ;
Biermann, William A. ;
Huang, James ;
Mino-Kenudson, Mari ;
Ramalingam, Suresh S. ;
West, Howard ;
Whitlock, Sara ;
Somerfield, Mark R. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (32) :3673-+
[10]  
Li Longyun, 2012, Zhongguo Fei Ai Za Zhi, V15, P332, DOI 10.3779/j.issn.1009-3419.2012.06.03
123